BUY SIDE BRO

ExxonMobil Holdings Corporation XOM

Latest Deep Dive · Written · AI research note

Bro's Verdict
Deep Dive

Rating

HOLD

Confidence

65%

Target Price

$178.00

Upside

+3.4%

Horizon

medium

XOM is a best-in-class integrated major with 13.1% net debt to capital and a dividend covered ~2.8x, but at $172.15 the 14.9x NTM P/E discount to its 2-year average reflects a declining earnings base (-8% NTM EPS, further step-down in FY+2) rather than a mispricing. Asset-based measures (1.8x EV/Revenue, 2.7x P/BV) are 1.6-1.8 SD above history and a DCF at 9.5% WACC yields only $130-$150, while the $178 target implies just ~3% price upside plus a 2.4% dividend. The bull case requires unproven Pioneer synergies, Permian at 2.0mboe/d and Guyana above 1.2mboe/d by 2027, plus refining margin normalisation — all plausible but already in the price, so we prefer to add on a pullback toward $150-$155.

Executive Summary

•XOM trades at 14.9x NTM EPS of $11.52, a 19% discount to its own 2 year average of 18.3x, yet asset based measures sit well above history at 1.8x EV/Revenue (+1.6 SD) and 2.7x P/BV (+1.8 SD), so the apparent value gap is earnings specific rather than a broad mispricing.
•Consensus NTM EPS of $11.52 implies -8% growth and FY+2 steps down again to $11.35, so the re rating case rests on Permian and Guyana volume growth plus a refining and chemicals recovery, not on near term earnings momentum.
•The balance sheet is best in class with net debt to capital of 13.1% and D/E of 15.9%, and the $4.12 annualised dividend is covered roughly 2.8x by NTM EPS, giving a 2.4% yield with low cut risk at strip prices.
•Sell side conviction has cooled to 21 Buy / 30 Hold / 4 Sell with a median target of $177, and the shares sit within 3% of the 52 week high of $176.41 after downgrades from Wells Fargo and BofA since July.

Financial Snapshot

•Market cap: $746.38b
•Revenue TTM: $361.06b
•Forward revenue NTM: $418.56b, +16% on TTM yet labelled -4.2% growth in the consensus feed, an internal inconsistency
•FY+2 revenue: $400.79b
•Gross margin TTM: 29.8%, with Q1 2026 compressing to 25%, the lowest in eight quarters
•Operating margin TTM: 15.9%
•Net margin TTM: 9.1%
•ROE: 12.6%
•D/E: 15.9%
•Net debt to capital: 13.1%
•TTM net income: ~$32.8b across the last four reported quarters
•Q2 2026 EPS: $3.48 reported, $3.52 adjusted
•Q1 2026 operating income: $5.29b, -46% year over year
•Q1 2026 revenue: $83.16b per company release versus $85.29b in the quarterly table, a minor reconciliation gap
•Dividend: $1.03 per quarter, $4.12 annualised, 2.4% yield
•Buyback pace: Not disclosed
•Price: $172.15, 52 week range $110.39 to $176.41

Forward Outlook

•NTM EPS consensus $11.52 (-8% year over year); FMP shows $12.34 (13.95x), a 7% higher figure that appears stale and would flatter the multiple
•FY+2 EPS $11.35, a further decline, so consensus models no earnings growth through 2028
•Permian: post Pioneer volumes around 1.5mboe/d, with guidance targeting ~2.0mboe/d by 2027; delivery against that path is the single largest swing factor
•Guyana: ~0.65mboe/d currently, targeting above 1.2mboe/d by 2027 as Yellowtail, Uaru and Whiptail ramp, with cash margins well above corporate average
•Pioneer synergies: target raised toward $4b per year by 2027 from the original $2b, with per barrel cost reductions in the Permian the key proof point
•Refining and chemicals: Q1 2026 operating income -46% year over year and gross margin at 25%; recovery to mid cycle is the second largest earnings lever after volumes
•Shareholder returns: dividend covered ~2.8x by NTM EPS; buyback pace not disclosed, so total return capacity at strip cannot be verified
•Low carbon and new energies: carbon capture, hydrogen, lower emission fuels and lithium (Smackover, first production targeted 2027) are optionality, but compete directly with core oil capex for capital
•Redomiciliation from New Jersey to Texas completed 1 July 2026, a structural change with no direct earnings impact

Valuation Analysis

•NTM P/E: 14.9x on consensus EPS of $11.52, or 13.95x on FMP's $12.34
•NTM P/S: 1.69x on FMP forward revenue, or ~1.78x on market cap of $746.38b over NTM revenue of $418.56b
•NTM EV/EBITDA: 8.0x versus 2 year average 7.7x (+5%, +0.1 SD)
•NTM EV/EBIT: 11.1x versus 2 year average 28.6x (-61%), distorted by a depressed base
•NTM EV/Revenue: 1.8x versus 1.3x average (+37%, +1.6 SD)
•LF P/BV: 2.7x versus 2.0x average (+37%, +1.8 SD)
•TTM P/E: ~22.8x on TTM EPS of ~$7.55, above CVX and COP on trailing earnings
•Implied price at 2 year average P/E of 18.3x: $211.98
•Implied price at average EV/EBITDA of 7.7x: $164.00
•Implied price at average EV/Revenue of 1.3x: $122.79
•Implied price at average P/BV of 2.0x: $125.37
•DCF (WACC 9.5%, terminal growth 2.5%, FCF of $31b rising to ~$45b by year 5): fair value $130 to $150, materially below the market price
•Sell side: consensus target $166.67, median $177, range $90 to $185
•CVX: 20.7x TTM P/E, $421.7b market cap, closest integrated peer
•SHEL: 11.2x TTM P/E, $289.0b market cap, cheapest major on trailing earnings
•COP: 18.2x TTM P/E, $165.3b market cap, pure play upstream with Permian leverage
•BP: 22.8x TTM P/E, $120.4b market cap, highest trailing multiple in the group
•Fair value range: $170 to $185; 12 month target $178, ~15.5x NTM EPS

Key Risks & Catalysts

Risks

•Forward EPS is already declining -8% and FY+2 steps lower again, so oil price weakness compounds into a lower multiple on lower earnings
•Asset based multiples at 1.8x EV/Revenue and 2.7x P/BV are 1.6 to 1.8 SD above 2 year averages, leaving little cushion if integrated major multiples compress
•Refining and chemicals remain at trough; Q1 2026 operating income fell 46% year over year and gross margin hit a multi quarter low
•Permian and Guyana volume delivery risk, where a slip against the 2027 targets removes the main growth pillar
•Pioneer synergy capture is a management target rather than a reported outcome, and per barrel cost reductions are unproven in the data provided
•DCF at a 9.5% WACC and 2.5% terminal growth implies $130 to $150, well below the $172.15 market price
•Institutional 13F data shows 206 holders and $0.9b of reported value (0.1% of shares), inconsistent with a mega cap of this size and likely a data artifact
•Recent downgrades from Wells Fargo (to Equal Weight) and BofA (to Neutral) point to sell side fatigue near the highs

Catalysts

•Q3 2026 results and any upward revision to Permian or Guyana volume guidance
•Refining margin normalisation toward mid cycle, which would lift Energy Products earnings sharply off a depressed base
•Chemicals margin recovery as industry capacity additions digest
•Confirmation of the Pioneer synergy run rate and disclosure of per barrel cost reductions
•Buyback pace disclosure or an increase to the return of capital framework
•Lithium first production from the Smackover and progress on carbon capture and hydrogen projects
•Completion of the Texas redomiciliation and any index or tax consequences
•Further consolidation in the Permian or Guyana at attractive valuations

Investment Thesis

XOM is a high quality integrated major with the strongest balance sheet in the peer group at 13.1% net debt to capital and a dividend covered roughly 2.8x by forward earnings. The problem is price. At $172.15 the shares trade at 14.9x NTM EPS of $11.52, a 19% discount to the 2 year average of 18.3x, which looks cheap until you note that forward EPS is falling -8% and FY+2 consensus steps down again to $11.35. The discount is compensation for a declining earnings base, not a mispricing.

Asset based measures tell the opposite story. EV/Revenue at 1.8x and P/BV at 2.7x are both 1.6 to 1.8 SD above their 2 year averages, and a DCF at a 9.5% WACC and 2.5% terminal growth yields $130 to $150. The market is already capitalising a mid cycle recovery in refining and chemicals plus full delivery on Permian and Guyana growth. That is a reasonable base case, but it is in the price, and the shares sit within 3% of the 52 week high.

Recommendation: Hold, 12 month target $178, about 15.5x NTM EPS, implying ~3% price upside plus a 2.4% dividend for a total return near 6%. The bull case requires $4b of Pioneer synergies, Permian at 2.0mboe/d and Guyana above 1.2mboe/d by 2027, plus refining margin normalisation; each is plausible but none is yet proven in reported numbers. Prefer to add on a pullback toward $150 to $155, which would restore the P/E discount without requiring the asset based multiples to expand further.

Written by Buy Side Bro's AI analyst from financials, consensus, filings and recent news. General information only, not financial advice.

Run your own analysis free

Buy Side Bro writes a note like this on any US, ASX or global stock in a few minutes: the thesis, valuation, catalysts, risks and a Buy, Hold or Sell call with a 12-month target. It comes with the daily market wrap, live markets, earnings and charts. Sign in and you get 7 days of full access free, no card needed.

iPhone app coming soon. The same account and subscription carry over.

See the latest research on other stocks